Carlos Nueno - 01 Sep 2026 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Reporting relationship: President, International
Issuer ticker: TDOC
Reported as of: 01 Sep 2026
Net transaction value: -$39,066
SEC form: 4
Accepted by SEC: 03 Sep 2026, 16:06:08 UTC
Prior SEC filing: 03 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Adam C. Vandervoort, Attorney-in-Fact

Key filing fact

Carlos Nueno filed Form 4 for Teladoc Health, Inc. (TDOC) on 03 Sep 2026.

Key facts

This page summarizes Carlos Nueno's Form 4 filing for Teladoc Health, Inc. (TDOC).
5 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 03 Sep 2026, 16:06.

Change

Previous filing in this sequence was filed on 03 Jun 2026.
Current net transaction value: -$39,066.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002037711 Primary reporting owner

Nueno Carlos

Relationship: President, International
Address: C/O TELADOC HEALTH, INC.,, 155 E 44TH ST, SUITE 1700, NEW YORK
Signature: /s/ Adam C. Vandervoort, Attorney-in-Fact
Signature date: 03 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TDOC transaction

Common Stock

Options Exercise

Transaction value
Shares: +4,556
Change %: +7.9%
Price
Shares after: 62,227
Date: 01 Sep 2026
Ownership: Direct
Footnotes: F1

TDOC transaction

Common Stock

Options Exercise

Transaction value
Shares: +8,717
Change %: +14%
Price
Shares after: 70,944
Date: 01 Sep 2026
Ownership: Direct
Footnotes: F1

TDOC transaction

Common Stock

Sale

Transaction value: $39,066
Shares: -6,200
Change %: -8.7%
Price: $6.30
Shares after: 64,744
Date: 02 Sep 2026
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TDOC transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares: -4,556
Change %: -33%
Price: $0.000000^*
Shares after: 9,114
Date: 01 Sep 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 4,556
Exercise price
Footnotes: F1, F3

TDOC transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares: -8,717
Change %: -14%
Price: $0.000000^*
Shares after: 52,302
Date: 01 Sep 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 8,717
Exercise price
Footnotes: F1, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

Footnote F2

Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.

Footnote F3

On March 19, 2024, the reporting person was granted 54,675 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.

Footnote F4

On March 1, 2025, the reporting person was granted 104,602 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.